112 related articles for article (PubMed ID: 2541069)
1. Recombinant human interleukin 1 alpha is cytotoxic for and increases surface expression of HLA-A,B,C antigens of a human hepatoma cell line, PLC/PRF/5.
Yoshioka K; Fuji A; Tahara H; Arao M; Kakumu S
Immunobiology; 1989 Feb; 178(4-5):380-9. PubMed ID: 2541069
[TBL] [Abstract][Full Text] [Related]
2. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
Tabor E; Kim CM
J Med Virol; 1991 May; 34(1):45-50. PubMed ID: 1715897
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant gamma interferon on hepatocellular carcinoma cell lines.
Ren EC; Wong LY; Chan SH
Cancer Lett; 1988 Apr; 39(3):305-10. PubMed ID: 2834043
[TBL] [Abstract][Full Text] [Related]
5. [A basic study of cytotoxic effect of tumor necrosis factor-alpha on the hepatoma cell line, PLC/PRF/5].
Takayama H; Takagi H; Saito S; Ojima T; Iizuka H; Katakai S; Yamada S; Kobayashi S
Nihon Shokakibyo Gakkai Zasshi; 1990 Feb; 87(2):195-8. PubMed ID: 2157910
[TBL] [Abstract][Full Text] [Related]
6. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon alpha, gamma, and tumor necrosis factor alpha on the HLA-A, B, C expression of cell lines derived from human liver.
Yoshioka K; Kakumu S; Tahara H; Arao M; Fuji A
Liver; 1989 Feb; 9(1):14-9. PubMed ID: 2493541
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of 5-azacytidine and gamma-interferon or dimethyl sulfoxide on expression of HLA class I antigens by PLC-PRF-5 cells.
Fukusato T; Mohamad A; Gerber MA; Thung SN
Tohoku J Exp Med; 1988 Jun; 155(2):117-28. PubMed ID: 2463698
[TBL] [Abstract][Full Text] [Related]
9. Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1.
Uckun FM; Myers DE; Fauci AS; Chandan-Langlie M; Ambrus JL
Blood; 1989 Aug; 74(2):761-76. PubMed ID: 2526668
[TBL] [Abstract][Full Text] [Related]
10. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines.
Hann HW; Stahlhut MW; Hann CL
Hepatology; 1990 Apr; 11(4):566-9. PubMed ID: 2158479
[TBL] [Abstract][Full Text] [Related]
11. Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.
Saito H; Tada S; Ebinuma H; Tsunematsu S; Kagawa T; Kumagai N; Inagaki Y; Watanabe T; Tsuchimoto K; Morizane T
J Gastroenterol; 1994 Dec; 29(6):733-9. PubMed ID: 7874268
[TBL] [Abstract][Full Text] [Related]
12. HLA expression in hepatocellular carcinoma cell lines.
Wadee AA; Paterson A; Coplan KA; Reddy SG
Clin Exp Immunol; 1994 Aug; 97(2):328-33. PubMed ID: 8050184
[TBL] [Abstract][Full Text] [Related]
13. Comparison of manganese superoxide dismutase precursor induction ability in human hepatoma cells with or without hepatitis B virus DNA insertion.
Hajnická V; Proost P; Kazár J; Fuchsberger N
Acta Virol; 2000 Dec; 44(6):343-7. PubMed ID: 11332277
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.
Wills PJ; Asha VV
J Ethnopharmacol; 2009 Mar; 122(2):294-303. PubMed ID: 19168119
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin on the growth of a human hepatoma cell line PLC/PRF/5: a possible role of insulin receptor.
Motoo Y; Kobayashi K; Hattori N
Tohoku J Exp Med; 1988 Dec; 156(4):351-7. PubMed ID: 2469133
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
Kilian PL; Kaffka KL; Stern AS; Woehle D; Benjamin WR; Dechiara TM; Gubler U; Farrar JJ; Mizel SB; Lomedico PT
J Immunol; 1986 Jun; 136(12):4509-14. PubMed ID: 2940296
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1 alpha and IL-1 beta binding sites.
Benjamin D; Wormsley S; Dower SK
J Biol Chem; 1990 Jun; 265(17):9943-51. PubMed ID: 2141025
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
